Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
Open Access
- 21 November 2012
- journal article
- review article
- Published by Hindawi Limited in Sarcoma
- Vol. 2012, 1-15
- https://doi.org/10.1155/2012/425636
Abstract
Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namely, proteomic studies, can offer important clues to understanding the tumor biology that cannot be obtained by other approaches. These studies, such as two-dimensional gel electrophoresis and mass spectrometry, have provided protein expression profiles of osteosarcoma that can be used to develop novel diagnostic and therapeutic biomarkers, as well as to understand biology of tumor progression and malignancy. In this paper, a brief description of the methodology will be provided followed by a few examples of the recent proteomic studies that have generated new information regarding osteosarcomas.Keywords
Funding Information
- Japan Society for the Promotion of Science (22791405)
This publication has 79 references indexed in Scilit:
- Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cellsOncogene, 2011
- Comparative proteomics analysis of human osteosarcomas and benign tumor of boneCancer Genetics and Cytogenetics, 2010
- Global Protein-expression Analysis of Bone and Soft Tissue SarcomasClinical Orthopaedics and Related Research, 2008
- Proteomics as a Method for Early Detection of Cancer: A Review of Proteomics, Exhaled Breath Condensate, and Lung Cancer ScreeningJournal of General Internal Medicine, 2007
- Identification of the functional role of peroxiredoxin 6 in the progression of breast cancerBreast Cancer Research, 2007
- ERM proteins in epithelial cell organization and functionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cellsExperimental Cell Research, 2006
- Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcomaGenes, Chromosomes and Cancer, 2003
- Expression of peroxiredoxin and thioredoxin in dermatological disordersBritish Journal of Dermatology, 2002
- Comparative genomic hybridization analysis identifies gains of 1p35∼p36 and chromosome 19 in osteosarcomaCancer Genetics and Cytogenetics, 2001